Law Firm Probes Option Care Health Amid M&A Shareholder Concerns
Monteverde & Associates is investigating Option Care Health over potential shareholder rights issues in a merger or acquisition deal.
A New York-based securities law firm has launched an investigation into Option Care Health, Inc., the Nasdaq-listed home and alternate-site infusion therapy company, according to an announcement released October 11, 2026.
Monteverde & Associates PC, whose principal attorney Juan Monteverde specializes in mergers-and-acquisitions litigation, is examining whether Option Care Health shareholders are receiving fair treatment in connection with a potential corporate transaction. The firm has previously recovered millions of dollars on behalf of investors in similar cases.
Read more Retail Investing Platforms Top 41 Million Accounts in Record Run →
Monteverde & Associates was recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report, a widely cited industry ranking that tracks plaintiff-side litigation activity. The designation signals the firm's volume and reach in securities class action matters.
Shareholder investigation announcements of this type are typically a precursor to a formal class action lawsuit if attorneys determine that corporate disclosures were inadequate or that a deal undervalues the target company. Investors who hold Option Care Health shares are generally encouraged by such firms to contact counsel before any shareholder vote or deal deadline.
Option Care Health trades on the Nasdaq under the ticker symbol OPCH. No charges or findings of wrongdoing have been established at this stage of the inquiry. Continue reading at All Financial Services & Investing.
